Oncology-Focused Venture Capital Firm Closes $30M Fund
Venture capital fund Oncology Ventures announced the close of an oversubscribed $30 million Fund I to invest in data-driven startups improving cancer care and research. New York-based Oncology Ventures is led by Ben Freeberg, a healthcare investor who previously served as vice president at Optum Ventures and was the first hire at Alpha Partners. Freeberg